Commentary: Building an evidence base for mendelian randomization studies: assessing the validity and strength of proposed genetic instrumental variables
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The remarkable growth in the popularity of mendelian randomization (MR) studies—analyses using genetic polymorphisms as instrumental variables (IVs)—reflects both the importance of the causal inference problems addressed by MR and the potential power of the approach.1 Although IV analysis is a well-established econometric tool, applications in health research using genetic information as IVs present novel challenges and opportunities. Papers such as that of Au Yeung et al., providing evidence on the characteristics of a proposed genetic IV for a specific phenotype-outcome association,2 are important because they help establish a foundation of evidence relevant for many future MR studies. In this commentary, we discuss the value of integrating evidence from external sources, such as the Au Yeung et al. results in MR studies, with specific focus on using separate-sample IV (SSIV, sometimes called split-sample IV) in data from case-control studies. Evaluating the validity of proposed genetic IVs entails first demonstrating that the genotype predicts the phenotype. A more serious challenge in evaluating an IV is to provide evidence for the assumption that the genotype has no causal links with the outcome of interest except via the phenotype of interest.3,4 Although this cannot be conclusively proven, statistical, theoretical or biological evidence may bolster this assumption if such evidence suggests direct pathways are unlikely. External evidence such as that provided by Au Yeung et al. can be used to quantify the genotype-phenotype association; to support the assumption of no other causal pathways between the genotype and the outcome; and, via SSIV, to derive IV effect estimates. IV analyses typically use two types of information: information on the association between the genotype and the phenotype, and information on the association between the genotype and the outcome. These two types of association can sometimes be evaluated using separate data sources. The SSIV method, described by Angrist et al. in the context of the two-stage least square (2SLS) IV estimator,5 is valid assuming that the associations observed in the data set used to estimate the genotype-phenotype association would also hold in the data set used to estimate the genotype-outcome association and vice versa. When external information about the association between proposed genetic instruments and the phenotype is available, the predicted value of X used in Equation 2 can be estimated based on this information. If the polymorphisms are thought to have independent, additive effects, the predicted value of X is simply the sum of the number of minor alleles times the estimated effect (as reported in the external study) of each minor allele on the phenotype. The coefficient for this weighted polygenic score predicting the outcome corresponds directly with the IV effect estimate. This approach has been implemented using beta weights from genome-wide association studies for body mass index,6 and, given the huge investments in estimating genotype-phenotype associations, it could be widely applicable. SSIV can be used if the phenotype of interest was either not measured or was measured with substantial error in the data set in which the outcome was assessed. SSIV also has the advantage of remediating weak-instruments bias, so there is less concern about using multiple polymorphisms as IVs, even if many of these polymorphisms are only weakly associated with the phenotype. To see this, note that if a set of genetic polymorphisms has no causal effect on a phenotype, a regression model using these polymorphisms to predict the phenotype will nonetheless typically be weakly predictive within any finite sample. The prediction will improve as more non-causal polymorphisms are used in the regression model, just as adding any random number as a predictor in a regression model always improves prediction R2 within the sample. The predicted phenotype value from such a model will be correlated with unmeasured causes of the phenotype within that sample, including those confounding factors that influence both the phenotype and the outcome. When this predicted phenotype value is used in the second stage of the 2SLS, it will also predict the outcome, due to its correlation with the confounders. As a result, the standard 2SLS IV estimate is biased towards the confounded conventional effect estimate when there are multiple IVs that have very small or no effects on the phenotype. This phenomenon is eliminated when the two stages are estimated in separate samples, because the association is not structural: the linear combination of the genotypes that by chance best predicts the phenotype in one sample is unrelated to the confounders of the phenotype-outcome association in the second sample. In health research, data are often drawn from case-control studies rather than representative samples and SSIV may be especially valuable in this context. We compare below some possib
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glymour, M. M., Tchetgen Tchetgen, E. J., & Robins, J. M. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr323 · Cited by 292
Self-citationAssumptions of IV Methods for Observational Epidemiology.
Didelez, V., Meng, S., & Sheehan, N. A. (2010) · Statistical Science · doi:10.1214/09-sts316 · Cited by 214
Cited by
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404
Methodological Challenges in Mendelian Randomization
VanderWeele, T. J., Tchetgen Tchetgen, E. J., Cornelis, M., & Kraft, P. (2014) · Epidemiology · doi:10.1097/ede.0000000000000081 · Cited by 555
Zhao, J., Jiang, C., Lam, T. H., Liu, B., Cheng, K. K., Xu, L., Au Yeung, S. L., Zhang, W., Leung, G. M., & Schooling, C. M. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyt239 · Cited by 53
Constrained instruments and their application to Mendelian randomization with pleiotropy
Jiang, L., Oualkacha, K., Didelez, V., Ciampi, A., Rosa‐Neto, P., Benedet, A. L., Mathotaarachchi, S., Richards, J. B., Greenwood, C. M. T., & Initiative, A. F. T. A. D. N. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22184 · Cited by 23
Metadata
- Authors
- Tchetgen Tchetgen, E. J., Walter, S., & Glymour, M. M.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02
- Volume
- 42
- Issue
- 1
- Pages
- 328-331
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2136598972
- Cited by
- 33
- References
- 2
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Commentary: Building an evidence base for mendelian randomization studies: assessing the validity and strength of proposed genetic instrumental variables. https://app.cochat.ai/papers/10.1093/ije/dyt023
- The paper
- Tchetgen Tchetgen, E. J., Walter, S., & Glymour, M. M. (2013). Commentary: Building an evidence base for mendelian randomization studies: assessing the validity and strength of proposed genetic instrumental variables. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyt023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.